Add to Favorites Newsroom RSS Share
Aurora, CO USA

Our News on Newswise


Brain Metastases Common and Difficult to Treat in ROS1 Lung Cancer

Brain metastases were found to be fairly common in stage IV ROS1-positive cancers and in 47 percent of ROS1 patients, the brain was the first and only site of progression.
10-Jul-2018 12:05 PM EDT Add to Favorites


Updated ALEX Trial Results Show Alectinib Further Outpacing Crizotinib in Treatment Naive ALK+ NSCLC

Dpdated data further consolidate alectinib as the standard-of-care for first-line treatment of ALK+ non-small cell lung cancer.
3-Jun-2018 7:05 AM EDT Add to Favorites


As Colorectal Cancer Rises in Young People, New Guidelines Recommend Screening Start at 45

Study published today the journal Cancer recommends colorectal cancer screening start at age 45, five years younger than currently recommended for both men and women of all races and ethnicities.
30-May-2018 11:05 AM EDT Add to Favorites


Ice Cream Funds Research Showing New Strategy Against Thyroid Cancer

University of Colorado Cancer Center study shows that stereotactic body radiation (SBRT) may be better against anaplastic thyroid cancer, and with fewer side effects.
21-May-2018 11:05 AM EDT Add to Favorites


Largest-Ever Study of Thyroid Cancer Genetics Finds New Mutations, Suggests Immunotherapy

CU researchers mine data of 583 patient samples of advanced differentiated thyroid cancer and 196 anaplastic thyroid cancers, showing genetic alterations, and "high mutation burden" that is an FDA-approved marker for immunotherapy.
26-Apr-2018 1:05 PM EDT Add to Favorites


Global ROS1 Initiative Combines Patient Experience with Researcher Expertise to Target ROS1 Cancer Wherever It Grows

University of Colorado Cancer Center study presented at AACR 2018 describes new model for patient-researcher collaboration organized not around cancer type but around oncogene that causes many cancers
9-Apr-2018 12:00 PM EDT Add to Favorites


Beyond PD-L1: Taking Away TIM3 and Tregs Stops Cancer Regrowth After Immunotherapy

CU Cancer Center study presented at AACR18 shows that TIM3 and/or increased regulatory T cells (Tregs) within a tumor may help cancers inactivate immune system killer T cells that would otherwise identify and attack the cancer.
9-Apr-2018 1:05 PM EDT Add to Favorites


When Prostate Cancer Reaches Bone, Bone Cells May Drive Overall Growth of the Disease

When prostate cancer metastasizes to bone, it can become especially dangerous – CU Cancer Center study at AACR18 hints at why: Cells involved in these bone metastases may release signals that drive the progression of the disease.
9-Apr-2018 2:05 PM EDT Add to Favorites

see all news

Our Experts on Newswise


Will One Bad Sunburn Give You Skin Cancer?

27-Jul-2015 11:05 AM EDT


Oncologists: How to Talk With Your Pathologist About Cancer Molecular Testing

An education session presented today at the American Society for Clinical Oncology (ASCO) Annual Meeting 2014 details the challenges of collaboration between oncologists and pathologists in the context of molecular testing patient tumor samples.
30-May-2014 4:00 PM EDT

see all experts

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.

Chat now!